Market Cap | 34.28M | P/E | - | EPS this Y | 59.30% | Ern Qtrly Grth | - |
Income | -124.65M | Forward P/E | -0.92 | EPS next Y | 39.90% | 50D Avg Chg | 15.00% |
Sales | 60.26M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -37.00% |
Dividend | N/A | Price/Book | 0.44 | EPS next 5Y | - | 52W High Chg | -88.00% |
Recommedations | 2.70 | Quick Ratio | 3.81 | Shares Outstanding | 6.03M | 52W Low Chg | 55.00% |
Insider Own | 16.89% | ROA | -28.31% | Shares Float | 4.13M | Beta | 0.57 |
Inst Own | 52.18% | ROE | -118.52% | Shares Shorted/Prior | 13.83K/30.61K | Price | 0.29 |
Gross Margin | 36.71% | Profit Margin | -206.85% | Avg. Volume | 443,666 | Target Price | 13.83 |
Oper. Margin | -60.40% | Earnings Date | May 13 | Volume | 463,264 | Change | 6.76% |
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.
Baird | Neutral | Jan 30, 24 |
Craig-Hallum | Hold | Jan 29, 24 |